Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
Move aligns global biologics identity under the Biocon Biologics brand
Safety was equally impressive. ENV-294 was well tolerated
Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
Subscribe To Our Newsletter & Stay Updated
